Showing results (161-170 of 205) with videos related to

Sort By:
Pageof 21
Plos One|January 26, 2011
Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461James I Mullins, Laura Heath, James P Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2021
PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineageYuezheng Zhang, Brendan F Kohrn, Ming Yang, et al.
Cancer|April 17, 2020
Long-term causes of death among pediatric patients with cancerSamantha R Horn, Kelsey C Stoltzfus, Heath B Mackley, et al.
Neurology|July 31, 2020
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE studyAmit Bar-Or, Jonathan C Calkwood, Cathy Chognot, et al.
Frontiers in Neurology|November 8, 2024
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosisEnrique Alvarez, Lawrence Steinman, Edward J Fox, et al.
Nature Communications|May 12, 2023
Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer's diseaseZhi Huang, Gennifer E Merrihew, Eric B Larson, et al.
Neuroscience Insights|October 9, 2023
Unveiling Resilience to Alzheimer's Disease: Insights From Brain Regional Proteomic MarkersZhi Huang, Gennifer E Merrihew, Eric B Larson, et al.
Frontiers in Immunology|June 15, 2026
Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosisDerrick Robertson, Enrique Alvarez, Lawrence Steinman, et al.
Neurology|August 12, 2016
The 11-year long-term follow-up study from the randomized BENEFIT CIS trialLudwig Kappos, Gilles Edan, Mark S Freedman, et al.
Brain : a Journal of Neurology|July 28, 2010
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunityJoanne L Jones, Jane M Anderson, Chia-Ling Phuah, et al.
Pageof 21